Fig 1: Mouse induced neural stem cells (iNSCs) exhibit stem cell characteristics in vitro. a-b: In vitro, iNSCs form neurospheres (a) and express NSC markers Sox2 (red) and Nestin (pseudocolored green). c-e: Following differentiation of iNSCs, constitutively expressed green fluorescent protein (GFP) is visible in all cells (c) while cells differentiated along an astrocytic lineage exhibit immunolabeling for GFAP (red, c). In addition, differentiation along neuronal (MAP2; red, d) and oligodendroglial (O4; red, e) lineages shows multipotency of iNSCs (GFP not shown). f: In non-differentiation conditions, iNSCs exhibit an exponential proliferation rate expected for stem cell growth based on quantification of each subculture after each passage. g: Quantification of iNSC multipotent differentiation from separately revived vials (n = 4). Data are mean values ± sem. Scale bar A = 100 μm, B, D, E = 20 μm, C = 40 μm
Fig 2: Analysis of Ki67 expression in the GFP/Sox2/GFAP positive cells. A) Immunostaining with GFP, GFAP, and Sox2 and the proliferative marker Ki67 in hippocampal sections of mice sacrificed 3 days after injection of control or Ncam2.1- or Ncam2.2-overexpressing lentiviruses. B) Immunostaining with GFP/GFAP/Sox2 and Ki67 in samples of mice sacrificed at 4 weeks postinjection. C) Percentage of Ki67-positive cells among the GFP/Sox2/GFAP progenitor population in mice injected with control, Ncam2.1-, or Ncam2.2-overexpressing viruses at 3 days postinjection. N = 3 animals per group, 5–10 sections per animal, 20–50 cells per animal. D) Quantifications of Ki67-positive cells among the GFP/Sox2/GFAP progenitors in mice injected with control, Ncam2.1-, or Ncam2.2-overexpressing viruses at 4 weeks postinjection. N = 3 animals per group, 5–10 sections per animal, 20–50 cells per animal. Data are presented as mean ± SEM; dots represent mean values for individual animals; ANOVA, Tukey’s comparison post hoc test; *P < 0.05. Arrowheads label GFP/Sox2/GFAP/Ki67-positive cells. ML: molecular layer; GL: granule layer; H: hilus; OE: overexpressing; d, day; w, week. Scale bars: A, B) 20 μm.
Fig 3: Characterization of EBs at early differentiation stagesRepresentative images of pluripotency (TRA-1-60 and Nanog) and neural stem cell (Nestin and Sox2) markers expression in EBs at different stages.
Fig 4: Characterization of GICs and non-initiating tumor cells. (A) High expression of SOX2 and low expression of Tuj1, GFAP and Galc were observed in GICs. In contrast, fewer SOX2 positive cells and more Tuj1, GFAP and Galc positive cells were observed in non-initiating tumor cells (×400). Scale bar=10 µm. (B) The percentage of positive cells expressing SOX2, GFAP, Galc and Tuj1. GICs, glioma-initiating cells; DAPI, 4′6-diamidino-2-phenylindole.
Fig 5: Shh pathway deregulation alters hippocampal astroglia. (A) Immunostaining and quantification of GFAP positive and (B) Sox2 positive astrocytes in the molecular layer (ML) of the hippocampus. Images, 100× magnification, scale bar = 10 μm. The number of mice used per test is indicated in the graphs (n). Data are reported as mean ± SEM **p < 0.01; ***p < 0.001 for comparison with controls (Student-t test).
Supplier Page from Abcam for Anti-SOX2 antibody